Literature DB >> 14959850

Deletion mapping of the long arm of chromosome 6 in peripheral T and NK cell lymphomas.

Jiyoung Yoon1, Young H Ko.   

Abstract

Deletion of chromosome 6q has frequently been observed in natural killer (NK) cell lymphomas. The aim of this study, is to localize the commonly affected region in chromosome 6q and to compare the frequency of loss of heterozygosity (LOH) between the peripheral T and NK cell lymphomas. Eight cases of peripheral T cell lymphomas, not otherwise characterized (PTCL-NOC), and 5 cases of nasal-type NK/T cell lymphomas were enrolled for the study. Twelve polymorphic markers covering the regions from 6q13 to 6q24, according to the Entrez Database (National Center for Biotechnology Information, NIH, Bethesta, MD), were used for LOH analysis. Results showed LOH at least one locus on chromosome 6q was observed in all cases. Of the informative cases, the overall frequency of LOH for each marker ranged from 8.3 to 58.3%. NK/T cell lymphomas showed a higher frequency of LOH compared to the PTCL (47.44 +/- 12.39 vs. 30.89 +/- 11.97%). The average frequency of LOH was 31.93 +/- 16.04% in stages I + II of the disease, whereas the average was 45.78 +/- 4.15% in stages III + IV. The most frequently involved regions were at markers D6S434 (5 of 8 informative cases, 62.5%) on chromosome 6q16.3 in the PTCL, D6S302 (4 of 5 cases, 80%) on chromosome 6q21 and D6S287 on 6q22.3 (4 of 5 cases, 80%) in the NK/T cell lymphoma. In conclusion, LOH of chromosome 6q is more common in nasal-type NK/T cell lymphoma than PTCL. The difference between the commonly lost region of chromosome 6q in NK/T cell lymphoma and that in PTCL suggests that different tumor suppressor genes are involved in the genetic evolution pathway of these two diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14959850     DOI: 10.1080/1042819031000123410

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  PRDM1 is a tumor suppressor gene in natural killer cell malignancies.

Authors:  Can Küçük; Javeed Iqbal; Xiaozhou Hu; Phillip Gaulard; Laurence De Leval; Gopesh Srivastava; Wing Yan Au; Timothy W McKeithan; Wing C Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.

Authors:  Christian Schmitt; Nouhoum Sako; Martine Bagot; Yenlin Huang; Philippe Gaulard; Armand Bensussan
Journal:  J Biomed Biotechnol       Date:  2011-04-20

3.  The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal Type.

Authors:  Li Liang; Zhang Zhang; Ying Wang; Lin Nong; Yalin Zheng; Linlin Qu; Bo Zhang; Ting Li
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

4.  The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.

Authors:  Li Liang; Lin Nong; Shuang Zhang; Jing Zhao; Hongjuan Ti; Ying Dong; Bo Zhang; Ting Li
Journal:  J Exp Clin Cancer Res       Date:  2014-01-17

Review 5.  The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma.

Authors:  Hyunsung Kim; Young Hyeh Ko
Journal:  Life (Basel)       Date:  2022-01-05

6.  Alternative Promoters of GRIK2 (GluR6) Gene in Human Carcinoma Cell Lines Are Regulated by Differential Methylation of CpG Dinucleotides.

Authors:  Vikramjit K Zhawar; Raj P Kandpal; Raghbir S Athwal
Journal:  Genes (Basel)       Date:  2022-03-10       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.